ISCT’s President-Elect Dr. Bruce Levine sat down with Bloomberg News to talk about how innovative, approved CAR-T therapies retrain the body’s immune system as an effective weapon to fight cancer. He also discusses the complex process of getting these groundbreaking therapies to the patient and into the market.
Archived link to podcast available here (talk with Bruce begins at 14:23) »
More News From ISCT
Press Releases